Haemodynamic effects of acute and chronic administration of low dose carvedilol, a vasodilating beta-blocker in patients with cirrhosis and portal hypertension

被引：0
|
作者：
Tripathi, D [1 ]
Therapondos, G [1 ]
Lui, HF [1 ]
Stanley, AJ [1 ]
Hayes, PC [1 ]
机构：
[1] Royal Infirm, Dept Med, Liver Unit, Edinburgh, Midlothian, Scotland
来源：
GUT | 2001年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
392
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [21] ACUTE HEMODYNAMIC-EFFECTS OF THE BETA-BLOCKER CARVEDILOL IN HEART-FAILURE
    BUCHWALD, A
    UNTERBERG, C
    VANDERDOES, R
    WIEGAND, V
    ZEITSCHRIFT FUR KARDIOLOGIE, 1990, 79 (06): : 424 - 428
  • [22] Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension
    Maggi, E
    Marchesi, E
    Covini, D
    Negro, C
    Perani, G
    Bellomo, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (04) : 532 - 538
  • [23] LACK OF EFFECT OF BETA-BLOCKER ON FLAT DOSE-RESPONSE TO THIAZIDE IN HYPERTENSION - EFFICACY OF LOW-DOSE THIAZIDE COMBINED WITH BETA-BLOCKER
    MACGREGOR, GA
    BANKS, RA
    MARKANDU, ND
    BAYLISS, J
    ROULSTON, J
    BRITISH MEDICAL JOURNAL, 1983, 286 (6377): : 1535 - 1538
  • [24] ORAL-ADMINISTRATION OF NIPRADILOL AND THE ACUTE AND CHRONIC SPLANCHNIC HEMODYNAMIC-EFFECTS OF A NEW BETA-BLOCKER WITH NITROVASODILATING PROPERTIES IN PATIENTS WITH LIVER-CIRRHOSIS
    SUGANO, S
    KAWAFUNE, T
    SUZUKI, T
    KUBOTA, M
    OKAJIMA, T
    SUMINO, Y
    AKITA, H
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1995, 90 (05): : 788 - 793
  • [25] Long term use of a non-selective beta-blocker with vasodilating properties carvedilol in patients with severe heart failure
    Zaikin, SY
    Iosava, IK
    Vasechkin, SS
    Gruzdev, AK
    Sidorenko, BA
    KARDIOLOGIYA, 2002, 42 (04) : 33 - 36
  • [26] Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis
    Sinagra, E.
    Perricone, G.
    D'Amico, M.
    Tine, F.
    D'Amico, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (06) : 557 - 568
  • [27] ANTIHYPERTENSIVE AND VASODILATING EFFECTS OF ACUTE MEDROXALOL, A NEW BETA-BLOCKER WITH BETA-2-ADRENERGIC RECEPTOR STIMULATION
    SIMON, A
    LEVENSON, J
    BOUTHIER, J
    MERLI, I
    JOURNAL DE PHARMACOLOGIE, 1986, 17 (03) : 331 - 337
  • [28] Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker
    Vachiery, F
    Moreau, R
    Gadano, A
    Yang, S
    Sogni, P
    Hadengue, A
    Cailmail, S
    Soupison, T
    Lebrec, D
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (09) : 1722 - 1726
  • [29] EFFICIENCY AND COMPLIANCE OF LOW-DOSE THERAPY WITH BETA-BLOCKER IN CHRONIC DIALYSIS, RENAL-INSUFFICIENCY AND PATIENTS WITH ARTERIAL-HYPERTENSION
    HUBER, W
    MULLER, T
    WOJTALLA, CJ
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1991, 20 (04) : 170 - 175
  • [30] Beta-Blocker Pretreatment Does Not Affect the Renoprotective Effects of Low-Dose Dopamine in Patients with Acute Decompensated Heart Failure
    Giamouzis, G.
    Butler, J.
    Starling, R. C.
    Karayannis, G.
    Rovithis, D.
    Parisis, C.
    Nastas, J.
    Tsaknakis, T.
    Skoularigis, J.
    Triposkiadis, F.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S112 - S113
12345